These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 448927)

  • 1. Analgesic Strategies in Patients With Amyotrophic Lateral Sclerosis #477.
    Meyers EE; Brizzi KT
    J Palliat Med; 2024 Apr; 27(4):565-566. PubMed ID: 38574339
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO drug Qalsody (tofersen) targets amyotrophic lateral sclerosis.
    Jin J; Zhong XB
    Trends Pharmacol Sci; 2023 Dec; 44(12):1043-1044. PubMed ID: 37709589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous treatment for ALS with implication for broad neuroprotection.
    Kim D; Kim S; Sung A; Patel N; Wong N; Conboy MJ; Conboy IM
    Transl Neurodegener; 2022 Mar; 11(1):16. PubMed ID: 35272709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-time penicillamine-treatment in amyotrophic lateral sclerosis with parallel determination of lead in blood, plasma and urine.
    Conradi S; Ronnevi LO; Nise G; Vesterberg O
    Acta Neurol Scand; 1982 Mar; 65(3):203-11. PubMed ID: 7080805
    [No Abstract]   [Full Text] [Related]  

  • 5. Determination of cerebrospinal fluid and serum lead levels in patients with amyotrophic lateral sclerosis and other neurological diseases.
    Kapaki E; Segditsa J; Zournas C; Xenos D; Papageorgiou C
    Experientia; 1989 Dec; 45(11-12):1108-10. PubMed ID: 2599056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penicillamine in amyotrophic lateral sclerosis.
    Bousser MG; Malier M
    Lancet; 1979 Jan; 1(8108):168. PubMed ID: 84200
    [No Abstract]   [Full Text] [Related]  

  • 7. [Spinal amyotrophy, delta-aminolevulinic acid and Metalcaptase (preliminary communication)].
    Jusić A; Sostarko M; Majić D
    Neurologija; 1979; 27(1-4):99-102. PubMed ID: 262024
    [No Abstract]   [Full Text] [Related]  

  • 8. Abnormal tissue distribution of lead in amyotrophic lateral sclerosis.
    Conradi S; Ronnevi LO; Vesterberg O
    J Neurol Sci; 1976 Oct; 29(2-4):259-65. PubMed ID: 978210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyotrophic lateral sclerosis.
    Check WA
    JAMA; 1979 Jul; 242(4):319. PubMed ID: 448927
    [No Abstract]   [Full Text] [Related]  

  • 10. Excitotoxic blocking strategies in amyotrophic lateral sclerosis.
    Hugon J
    Adv Neurol; 1995; 68():245-52; discussion 253-8. PubMed ID: 8787237
    [No Abstract]   [Full Text] [Related]  

  • 11. [Progress in the treatment of degenerative diseases of the nervous system. Selected problems].
    Zaleska B
    Neurol Neurochir Pol; 1980; 14(2):209-12. PubMed ID: 6446688
    [No Abstract]   [Full Text] [Related]  

  • 12. Intrathecal thyrotropin-releasing hormone in amyotrophic lateral sclerosis.
    Munsat TL; Taft J; Kasdon D
    Neurol Clin; 1987 Feb; 5(1):159-70. PubMed ID: 3104751
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.